Loading...
A Review of Functional Neuroimaging in People with down Syndrome with and without Dementia
Lau, Lilian Suh Lih
Lau, Lilian Suh Lih
Abstract
Background: Individuals with Down syndrome (DS) are at high risk of dementia which is difficult to diagnose in DS. Neuroimaging has been identified as a potential tool to aid diagnosis by detecting changes in brain function. We carried out a review comparing functional neuroimaging in DS individuals with and without dementia. Summary: A literature search was conducted using PubMed to identify relevant studies. In DS subjects with dementia, fluorodeoxyglucose-positron emission tomography (PET) studies showed glucose hypometabolism particularly in the parietal and/or temporal regions whilst magnetic resonance spectroscopy studies showed increased myoinositol and decreased N-acetylaspartate. Ligand-based PET studies revealed significant Pittsburgh compound B binding in DS subjects over the age of 40, particularly if they had dementia. Key Messages: Neuroimaging may aid the early detection of dementia in DS; however, further longitudinal studies are required.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2021-09
Type
Article
Collections
Citation
Funmi Deinde et al. (2021) ‘A Review of Functional Neuroimaging in People with Down Syndrome with and without Dementia’, Dementia and Geriatric Cognitive Disorders Extra, 11(3), pp. 324–332
